{"id":50627,"date":"2022-11-08T18:02:12","date_gmt":"2022-11-08T17:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/"},"modified":"2022-11-08T18:02:12","modified_gmt":"2022-11-08T17:02:12","slug":"systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/","title":{"rendered":"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4521365\/systemic-lupus-erythematosus-sle-update?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sb5sh5&amp;utm_campaign=1773199+-+Systemic+Lupus+Erythematosus+(SLE)+Update+Bulletin+2022%3A+Gain+Insights+on+the+Latest+Events+Happening+in+the+Treatment+Landscape&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Systemic Lupus Erythematosus (SLE): Update Bulletin #2&#8221;<\/a> newsletter has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/21\/logo.jpg\"><\/a><\/p>\n<p>\nGain new key opinion leader (KOL) insights on the latest events happening in Systemic Lupus Erythematosus (SLE) treatment landscape.\n<\/p>\n<p>\nTopics covered include expert opinions on the prospects of the Phase III BLISS-BELIEVE study which will assess co-administration of SC Benylsta (GSK&#8217;s belimumab) and a single cycle of IV Rituxan\/MabThera (rituximab; Roche\/Biogen).\n<\/p>\n<p>\nThe KOLs also imparted their views on the results of a Phase II study investigating Stelara (ustekinumab; Janssen Biotech) for the treatment of SLE, and the potential for XTL Biopharmaceuticals&#8217; edratide as well as Corbus Pharmaceuticals&#8217;s anabasum.\n<\/p>\n<p>\n<strong>Business Questions:<\/strong>\n<\/p>\n<ul>\n<li>\nHow do KOLs view the combination of belimumab and rituximab for the treatment of SLE? Do KOLs harbour any concerns about combining these two biologic agents?\n<\/li>\n<li>\nHow do experts view the results of ustekinumab&#8217;s Phase II study?\n<\/li>\n<li>\nWhat advantages does ustekinumab have over other pipeline SLE agents?\n<\/li>\n<li>\nHow do KOLs perceive edratide&#8217;s mechanism of action and preliminary trial results?\n<\/li>\n<li>\nHow optimistic are KOLs about edratide&#8217;s prospects as a treatment for SLE?\n<\/li>\n<li>\nDo KOLs perceive anabasum&#8217;s mechanism of action to be promising?\n<\/li>\n<li>\nHow do KOLs view this agent&#8217;s safety profile?\n<\/li>\n<\/ul>\n<p>\nFor more information about this newsletter visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4521365\/systemic-lupus-erythematosus-sle-update?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sb5sh5&amp;utm_campaign=1773199+-+Systemic+Lupus+Erythematosus+(SLE)+Update+Bulletin+2022%3A+Gain+Insights+on+the+Latest+Events+Happening+in+the+Treatment+Landscape&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/rggx5q<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;p&#x72;&#101;s&#x73;&#64;&#x72;&#x65;s&#x65;&#97;r&#x63;&#104;a&#x6e;&#100;&#x6d;&#x61;&#114;&#x6b;&#x65;t&#x73;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;&#x65;&#x73;&#115;&#x40;&#114;e&#x73;&#101;a&#x72;&#99;h&#x61;&#110;d&#x6d;&#97;&#x72;&#x6b;&#101;&#x74;&#x73;&#46;&#x63;&#111;m<\/a>\n<\/p>\n<p>\nFor E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Systemic Lupus Erythematosus (SLE): Update Bulletin #2&#8221; newsletter has been added to ResearchAndMarkets.com&#8217;s offering. Gain new key opinion leader (KOL) insights on the latest events happening in Systemic Lupus Erythematosus (SLE) treatment landscape. Topics covered include expert opinions on the prospects of the Phase III BLISS-BELIEVE study which will assess co-administration of SC &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50627","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Systemic Lupus Erythematosus (SLE): Update Bulletin #2&#8221; newsletter has been added to ResearchAndMarkets.com&#8217;s offering. Gain new key opinion leader (KOL) insights on the latest events happening in Systemic Lupus Erythematosus (SLE) treatment landscape. Topics covered include expert opinions on the prospects of the Phase III BLISS-BELIEVE study which will assess co-administration of SC ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-08T17:02:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-08T17:02:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/\"},\"wordCount\":280,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005903\\\/en\\\/1629533\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/\",\"name\":\"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005903\\\/en\\\/1629533\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-08T17:02:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005903\\\/en\\\/1629533\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005903\\\/en\\\/1629533\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Systemic Lupus Erythematosus (SLE): Update Bulletin #2&#8221; newsletter has been added to ResearchAndMarkets.com&#8217;s offering. Gain new key opinion leader (KOL) insights on the latest events happening in Systemic Lupus Erythematosus (SLE) treatment landscape. Topics covered include expert opinions on the prospects of the Phase III BLISS-BELIEVE study which will assess co-administration of SC ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-08T17:02:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape &#8211; ResearchAndMarkets.com","datePublished":"2022-11-08T17:02:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/"},"wordCount":280,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/","name":"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/21\/logo.jpg","datePublished":"2022-11-08T17:02:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221108005903\/en\/1629533\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Systemic Lupus Erythematosus (SLE) Update Bulletin 2022: Gain Insights on the Latest Events Happening in the Treatment Landscape &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50627"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50627\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}